Safety of blonanserin and paliperidone extended-release in patients with acute schizophrenia.

Trial Profile

Safety of blonanserin and paliperidone extended-release in patients with acute schizophrenia.

Completed
Phase of Trial: Phase II

Latest Information Update: 20 Oct 2013

At a glance

  • Drugs Blonanserin (Primary) ; Paliperidone (Primary)
  • Indications Schizophrenia
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 20 Oct 2013 New trial record
    • 09 Oct 2013 Results presented at the 26th Annual Congress of the European College of Neuropsychopharmacology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top